Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126281362 | 12628136 | 2 | F | 201607 | 20160812 | 20160808 | 20160818 | EXP | BR-ASTRAZENECA-2016SE84312 | ASTRAZENECA | 485.00 | MON | M | Y | 118.00000 | KG | 20160819 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126281362 | 12628136 | 1 | PS | ATACAND | CANDESARTAN CILEXETIL | 1 | Oral | 20838 | 8 | MG | TABLET | QD | |||||||
| 126281362 | 12628136 | 2 | SS | ATACAND | CANDESARTAN CILEXETIL | 1 | Oral | 20838 | 16 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126281362 | 12628136 | 1 | Hypertension |
| 126281362 | 12628136 | 2 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126281362 | 12628136 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126281362 | 12628136 | Blood pressure inadequately controlled | |
| 126281362 | 12628136 | Blood pressure increased | |
| 126281362 | 12628136 | Headache |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126281362 | 12628136 | 1 | 201003 | 0 |